← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · MEDICATION

Prednisolone

A glucocorticoid used for anti-inflammatory or immunosuppressive effects. Orapred and Pediapred are human prednisolone brands; use in animals is extra-label and depends on the disease, formulation and prescribing veterinarian’s plan.

Systemic glucocorticoidProduct-specific clinical reference

Updated October 16, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

Prednisolone sodium-phosphate human ODT and liquid formulations are not automatically interchangeable.

Key prescribing checks

  • Review infection risk, diabetes, gastrointestinal disease and other immunosuppressants. Glucocorticoids can mask signs of infection and alter glucose control.
  • Reconcile NSAIDs because combination increases gastrointestinal risk; the prescriber must plan any change between anti-inflammatory classes.
  • Sustained systemic therapy may suppress adrenal function. Withdrawal and taper decisions require clinical direction; this identity lookup does not supply a taper protocol.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Dogs and cats

Extra-label

Veterinarian-selected inflammatory or immune-mediated disease

Orapred ODT human labeling does not authorize animal treatment.

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Produces anti-inflammatory and immunosuppressive effects with broad metabolic actions.

Absorption, distribution, metabolism and elimination

Animal-specific pharmacokinetic parameters were not established by the reviewed label.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Orapred ODT

Human prednisolone sodium-phosphate orally disintegrating tablets; veterinary use is extra-label.

Contraindications · when not to use

  • Prednisolone or ingredient hypersensitivity.

Precautions & monitoring

  • Warnings advise avoiding systemic fungal infection except to control drug reactions; monitor infection, adrenal suppression, glucose, blood pressure and gastrointestinal disease. Do not break tablets.

Pediapred

Human prednisolone sodium-phosphate solution; veterinary use is extra-label.

Contraindications · when not to use

  • Systemic fungal infection; drug or ingredient hypersensitivity.

Precautions & monitoring

  • Infection can worsen or be masked; adrenal suppression and metabolic/cardiovascular effects require monitoring.

Systemic fungal infection is a formal contraindication for Pediapred but appears under warnings for Orapred ODT.

Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

Infection, adrenal suppression, hyperglycemia and gastrointestinal effects are important systemic steroid risks.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.

A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.

A veterinary dose was not verified. Indication, duration and taper require a veterinarian; no human regimen is supplied.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Orapred ODT

Human prednisolone sodium-phosphate orally disintegrating tablets; veterinary use is extra-label.

  • NSAIDs increase gastrointestinal risk. Review anticoagulants, antidiabetics, CYP3A4 modifiers and cyclosporine; avoid live vaccines during immunosuppressive therapy.
Interaction source ↗

Pediapred

Human prednisolone sodium-phosphate solution; veterinary use is extra-label.

  • Review live vaccines, anticoagulants, aspirin, potassium-depleting drugs and hepatic enzyme modifiers.
Interaction source ↗

Monitoring

Assess infection, glucose, blood pressure and prolonged-treatment adrenal suppression.

Client counseling

Do not abruptly change prolonged therapy; obtain a taper plan. Review NSAIDs and vaccines.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Follow the formulation label; Orapred ODT tablets must not be broken.

Brands, formulations & ingredient identity

Active ingredients

Prednisolone

Other searchable names: Prednisolone sodium phosphate

Prednisolone and prednisone are different active ingredients; they should not be combined into one synonym record.

Orapred ODT is an orally disintegrating sodium-phosphate tablet; Pediapred is a sodium-phosphate oral solution. Their ingredient relationship does not make administration or concentration interchangeable.

Confirm that strength is expressed as prednisolone base equivalent. Orapred ODT labeling says the fragile tablets are not intended to be split, cut or broken.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Orapred ODT

Formulation
Orally disintegrating tablets
Label / product scope
Human product

Human sodium-phosphate formulation; check base-equivalent strength and do not split ODT tablets.

Product label / source ↗

Pediapred

Formulation
Oral solution
Label / product scope
Human product

Human sodium-phosphate solution; verify concentration rather than transferring tablet instructions.

Product label / source ↗

References & review status

Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

Search another medication or supplement →

CONTINUE EXPLORING

Use these connected guides to prepare informed questions for your veterinary team.

Find Veterinary Care Near YouLocate general practices, urgent-care clinics, emergency hospitals and specialists.Read resource →When It Is an EmergencyRecognize signs that require immediate veterinary care.Read resource →Interactive Symptom NavigatorStart with what you notice and understand when to seek help.Read resource →Poisons and Household HazardsRecognize common exposures and avoid unsafe home treatment.Read resource →Printable Owner ToolkitBring observations, medication details and questions to your appointment.Read resource →
Privacy & cookie choices